{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:32:47Z","timestamp":1784842367192,"version":"3.55.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Bambino Ges\u00f9 Children\u2019s Hospital"},{"name":"Boston Children\u2019s Hospital Department of Pediatrics"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Immunization of vulnerable populations with distinct immunity often results in suboptimal immunogenicity, durability, and efficacy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Safety and immunogenicity profiles of BNT162b2 messenger RNA coronavirus disease 2019 (COVID-19) vaccine, among people living with human immunodeficiency virus (HIV), were evaluated in 28 perinatally HIV-infected patients under antiretroviral therapy (ART) and 65 healthy controls (HCs) with no previous history of COVID-19. Thus, we measured severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\u2013specific humoral and CD4+ T cell responses. Samples were collected before vaccination (baseline, day [D] 0), at the second dose (D21), and at 4 weeks (D28) and 6 months (D180) after D0. Proteomic profiles at D0 and D28 were assessed with a multiplexed proximity extension assay (Olink) on plasma samples.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>All HIV-infected patients mounted similar anti\u2013SARS-CoV-2 humoral responses to those of HCs, albeit with lower titers of anti-trimeric S at D28 (P\u2009=\u2009.01). Only peripheral blood mononuclear cells of HIV-infected patients demonstrated at D28 an impaired ability to expand their specific (CD40L+) CD4+ T-cell populations. Similar humoral titers were maintained between the 2 groups at 6-months follow-up. We additionally correlated baseline protein levels to either humoral or cellular responses, identifying clusters of molecules involved in immune response regulation with inverse profiles between the 2 study groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Responses of ART-treated HIV-infected patients, compared to those of HCs, were characterized by distinct features especially within the proteomic compartment, supporting their eligibility to an additional dose, similarly to the HC schedule.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciac408","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T22:38:37Z","timestamp":1656023917000},"page":"S51-S60","source":"Crossref","is-referenced-by-count":18,"title":["Perinatally Human Immunodeficiency Virus\u2013Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity"],"prefix":"10.1093","volume":"75","author":[{"given":"Elena","family":"Morrocchi","sequence":"first","affiliation":[{"name":"Academic Department of Pediatrics, Research Unit of Clinical Immunology and Vaccinology, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"},{"name":"Precision Vaccines Program, Boston Children\u2019s Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pighi","sequence":"additional","affiliation":[{"name":"Academic Department of Pediatrics, Research Unit of Clinical Immunology and Vaccinology, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Rubens","family":"Pascucci","sequence":"additional","affiliation":[{"name":"Academic Department of Pediatrics, Research Unit of Clinical Immunology and Vaccinology, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"},{"name":"Department of Systems Medicine, University of Rome \u201cTor Vergata,\u201d Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Cotugno","sequence":"additional","affiliation":[{"name":"Academic Department of Pediatrics, Research Unit of Clinical Immunology and Vaccinology, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"},{"name":"Department of Systems Medicine, University of Rome \u201cTor Vergata,\u201d Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Medri","sequence":"additional","affiliation":[{"name":"Academic Department of Pediatrics, Research Unit of Clinical Immunology and Vaccinology, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Amodio","sequence":"additional","affiliation":[{"name":"Academic Department of Pediatrics, Research Unit of Clinical Immunology and Vaccinology, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luna","family":"Colagrossi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ruggiero","sequence":"additional","affiliation":[{"name":"Academic Department of Pediatrics, Research Unit of Clinical Immunology and Vaccinology, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Concetta","family":"Manno","sequence":"additional","affiliation":[{"name":"Academic Department of Pediatrics, Research Unit of Clinical Immunology and Vaccinology, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Casamento Tumeo","sequence":"additional","affiliation":[{"name":"General Pediatrics Unit, Department of Emergency, Acceptance and General Pediatrics, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bernardi","sequence":"additional","affiliation":[{"name":"Academic Department of Pediatrics, Research Unit of Clinical Immunology and Vaccinology, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga K","family":"Smolen","sequence":"additional","affiliation":[{"name":"Precision Vaccines Program, Boston Children\u2019s Hospital , Boston, Massachusetts , USA"},{"name":"Harvard Medical School, Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Federico","family":"Perno","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al","family":"Ozonoff","sequence":"additional","affiliation":[{"name":"Precision Vaccines Program, Boston Children\u2019s Hospital , Boston, Massachusetts , USA"},{"name":"Harvard Medical School, Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Rossi","sequence":"additional","affiliation":[{"name":"Academic Department of Pediatrics, Research Unit of Clinical Immunology and Vaccinology, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Levy","sequence":"additional","affiliation":[{"name":"Precision Vaccines Program, Boston Children\u2019s Hospital , Boston, Massachusetts , USA"},{"name":"Harvard Medical School, Boston, Massachusetts , USA"},{"name":"Broad Institute of Massachusetts Institute of Technology and Harvard , Cambridge, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Palma","sequence":"additional","affiliation":[{"name":"Academic Department of Pediatrics, Research Unit of Clinical Immunology and Vaccinology, Bambino Ges\u00f9 Children\u2019s Hospital , Rome , Italy"},{"name":"Precision Vaccines Program, Boston Children\u2019s Hospital , Boston, Massachusetts , USA"},{"name":"Department of Systems Medicine, University of Rome \u201cTor Vergata,\u201d Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"2022081503564919200_ciac408-B1","doi-asserted-by":"crossref","first-page":"e2095","DOI":"10.1093\/cid\/ciaa1605","article-title":"Outcomes of coronavirus disease 2019 (COVID-19) related hospitalization among people with human immunodeficiency virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): a prospective observational study","volume":"73","author":"Geretti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022081503564919200_ciac408-B2","doi-asserted-by":"crossref","first-page":"e2037069","DOI":"10.1001\/jamanetworkopen.2020.37069","article-title":"COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York state","volume":"4","author":"Tesoriero","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2022081503564919200_ciac408-B3","doi-asserted-by":"crossref","first-page":"e2005","DOI":"10.1093\/cid\/ciaa1198","article-title":"Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape Province, South Africa","volume":"73","author":"Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases South Africa","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022081503564919200_ciac408-B4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/hiv.13202","article-title":"Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy","volume":"23","author":"Jedicke","year":"2021","journal-title":"HIV Med"},{"key":"2022081503564919200_ciac408-B5","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jmv.26321","article-title":"HIV\/SARS-CoV-2 coinfection: a global perspective","volume":"93","author":"Kanwugu","year":"2021","journal-title":"J Med Virol"},{"key":"2022081503564919200_ciac408-B6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"2022081503564919200_ciac408-B7","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"2022081503564919200_ciac408-B8","doi-asserted-by":"crossref","first-page":"727850","DOI":"10.3389\/fimmu.2021.727850","article-title":"Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies","volume":"12","author":"Amodio","year":"2021","journal-title":"Front Immunol"},{"key":"2022081503564919200_ciac408-B9","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1097\/TP.0000000000003999","article-title":"Bnt162b2 mRNA COVID-19 vaccine in heart and lung transplanted young adults: is an alternative SARS-CoV-2 immune response surveillance needed?","volume":"106","author":"Cotugno","year":"2022","journal-title":"Transplantation"},{"key":"2022081503564919200_ciac408-B10","doi-asserted-by":"crossref","first-page":"100174","DOI":"10.1016\/j.pvr.2019.100174","article-title":"HPV vaccination in HIV infection","volume":"8","author":"Lacey","year":"2019","journal-title":"Papillomavirus Res"},{"key":"2022081503564919200_ciac408-B11","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/QAD.0000000000000772","article-title":"The impact of vaccination on the breadth and magnitude of the antibody response to influenza A viruses in HIV-infected individuals","volume":"29","author":"Kohler","year":"2015","journal-title":"AIDS"},{"key":"2022081503564919200_ciac408-B12","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1097\/QAD.0b013e32833c6d5c","article-title":"Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals","volume":"24","author":"Tebas","year":"2010","journal-title":"AIDS"},{"key":"2022081503564919200_ciac408-B13","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/cid\/ciab648","article-title":"The BNT162b2 mRNA vaccine elicits robust humoral and cellular immune responses in people living with human immunodeficiency virus (HIV)","volume":"74","author":"Woldemeskel","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2022081503564919200_ciac408-B14","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.cmi.2021.07.031","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1","volume":"27","author":"Levy","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2022081503564919200_ciac408-B15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/joim.13419","article-title":"Humoral response to two doses of BNT162b2 vaccination in people with HIV","volume":"291","author":"Heftdal","year":"2022","journal-title":"J Intern Med"},{"key":"2022081503564919200_ciac408-B16","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1016\/S2352-3018(21)00099-0","article-title":"Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV","volume":"8","author":"Touizer","year":"2021","journal-title":"Lancet HIV"},{"key":"2022081503564919200_ciac408-B17","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"key":"2022081503564919200_ciac408-B18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","article-title":"Bnt162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans","volume":"595","author":"Sahin","year":"2021","journal-title":"Nature"},{"key":"2022081503564919200_ciac408-B19","doi-asserted-by":"crossref","first-page":"100046","DOI":"10.1016\/j.jve.2021.100046","article-title":"Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers","volume":"7","author":"Zaffina","year":"2021","journal-title":"J Virus Erad"},{"key":"2022081503564919200_ciac408-B20","doi-asserted-by":"crossref","first-page":"M110.004978","DOI":"10.1074\/mcp.M110.004978","article-title":"Multiplexed homogeneous proximity ligation assays for high-throughput protein biomarker research in serological material","volume":"10","author":"Lundberg","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"2022081503564919200_ciac408-B21","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/pai.13585","article-title":"Virological and immunological features of SARS-COV-2\u2013infected children with distinct symptomatology","volume":"32","author":"Cotugno","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"2022081503564919200_ciac408-B22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformat"},{"key":"2022081503564919200_ciac408-B23","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/QAD.0000000000003017","article-title":"Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV","volume":"35","author":"Ruddy","year":"2021","journal-title":"AIDS"},{"key":"2022081503564919200_ciac408-B24","doi-asserted-by":"crossref","first-page":"e544","DOI":"10.1016\/S2666-7568(21)00168-9","article-title":"Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study","volume":"2","author":"Tut","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"2022081503564919200_ciac408-B25","doi-asserted-by":"crossref","first-page":"e3000257","DOI":"10.1371\/journal.pbio.3000257","article-title":"Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: results from the FLORAH study","volume":"17","author":"Pallikkuth","year":"2019","journal-title":"PLoS Biology"},{"key":"2022081503564919200_ciac408-B26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jmv.25585","article-title":"Induction of peripheral blood T follicular helper cells expressing ICOS correlates with antibody response to hepatitis B vaccination","volume":"92","author":"Xing","year":"2020","journal-title":"J Med Virol"},{"key":"2022081503564919200_ciac408-B27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/v11030200","article-title":"Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART","volume":"11","author":"Zicari","year":"2019","journal-title":"Viruses"},{"key":"2022081503564919200_ciac408-B28","doi-asserted-by":"crossref","first-page":"658420","DOI":"10.3389\/fimmu.2021.658420","article-title":"Mitochondrial functions are compromised in CD4 T cells from ART-controlled PLHIV","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Immunol"},{"key":"2022081503564919200_ciac408-B29","doi-asserted-by":"publisher","article-title":"The immune signatures data resource: a compendium of systems vaccinology datasets","author":"Diray-Arce","DOI":"10.1101\/2021.11.05.465336"},{"key":"2022081503564919200_ciac408-B30","doi-asserted-by":"publisher","article-title":"An innate immune activation state prior to vaccination predicts responsiveness to multiple vaccines","author":"Fourati","DOI":"10.1101\/2021.09.26.461847"},{"key":"2022081503564919200_ciac408-B31","doi-asserted-by":"crossref","first-page":"590373","DOI":"10.3389\/fimmu.2020.590373","article-title":"Towards precision vaccines: lessons from the Second International Precision Vaccines Conference","volume":"11","author":"Soni","year":"2020","journal-title":"Front Immunol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac408\/44828315\/ciac408.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/Supplement_1\/S51\/45407543\/ciac408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/Supplement_1\/S51\/45407543\/ciac408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T03:57:19Z","timestamp":1660535839000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/Supplement_1\/S51\/6615389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":31,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2022,6,23]]},"published-print":{"date-parts":[[2022,8,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac408","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,15]]},"published":{"date-parts":[[2022,6,23]]}}}